Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Rate of T-downstaging (Reduction of the T-stadium) at the time of final surgery following the
preoperative combined radiochemotherapy (chemotherapy: Oxaliplatin, Capecitabine) Evaluation
of the toxicity grade III and IV of the therapy scheme